Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2024 ▲▼ | Q2 2024 ▲▼ | Change ▲▼ | Q1 2024 ▲▼ | Q2 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Newamsterdam Pharma Company ORDINARY SHARES | 12,226,943 | 12,226,943 | 0 | $289.17M | $234.88M | 10.99% | -$54.29M |
| Mirum Pharmaceuticals, Inc.(MIRM) | 6,495,392 | 6,495,392 | 0 | $163.16M | $222.08M | 10.39% | +$58.91M |
| Krystal Biotech, Inc.(KRYS) | 988,460 | 988,460 | 0 | $175.88M | $181.52M | 8.49% | +$5.64M |
| Hillevax Inc | 9,781,472 | 10,617,062 | +835,590 | $162.67M | $153.52M | 7.18% | -$9.14M |
| Phathom Pharmaceuticals, Inc.(PHAT) | 10,109,279 | 10,109,279 | 0 | $107.36M | $104.13M | 4.87% | -$3.23M |
| Rhythm Pharmaceuticals, Inc.(RYTM) | 2,190,179 | 2,371,304 | +181,125 | $94.90M | $97.37M | 4.55% | +$2.47M |
| BridgeBio Pharma, Inc.(BBIO) | 3,415,604 | 3,632,604 | +217,000 | $105.61M | $92.01M | 4.30% | -$13.60M |
| Arcutis Biotherapeutics, Inc.(ARQT) | 8,785,284 | 8,785,284 | 0 | $87.06M | $81.70M | 3.82% | -$5.36M |
| Disc Medicine, Inc.(IRON) | 785,000 | 1,754,834 | +969,834 | $48.87M | $79.09M | 3.70% | +$30.22M |
| Vaxcyte, Inc.(PCVX) | 1,139,405 | 1,039,405 | -100,000 | $77.83M | $78.49M | 3.67% | +$652.7K |
| Edgewise Therapeutics, Inc.(EWTX) | 3,303,567 | 3,731,067 | +427,500 | $60.26M | $67.20M | 3.14% | +$6.94M |
| Anaptysbio Inc | 899,700 | 2,165,591 | +1,265,891 | $20.26M | $54.27M | 2.54% | +$34.01M |
| Verona Pharma PlcADS | 3,014,349 | 3,314,349 | +300,000 | $48.50M | $47.93M | 2.24% | -$575.4K |
| Kalvista Pharmaceuticals Inc | 3,687,867 | 3,687,867 | 0 | $43.74M | $43.44M | 2.03% | -$295.0K |
| Tarsus Pharmaceuticals, Inc.(TARS) | 1,787,527 | 1,587,527 | -200,000 | $64.98M | $43.15M | 2.02% | -$21.83M |
| Revolution Medicines, Inc.(RVMD) | 997,455 | 997,455 | 0 | $32.15M | $38.71M | 1.81% | +$6.56M |
| Erasca, Inc.(ERAS) | 0 | 16,216,216 | +16,216,216 | $0 | $38.27M | 1.79% | +$38.27M |
| Agios Pharmaceuticals, Inc.(AGIO) | 523,166 | 871,974 | +348,808 | $15.30M | $37.60M | 1.76% | +$22.30M |
| Soleno Therapeutics Inc | 875,667 | 875,667 | 0 | $37.48M | $35.73M | 1.67% | -$1.75M |
| Rocket Pharmaceuticals, Inc.(RCKT) | 1,561,230 | 1,561,230 | 0 | $42.06M | $33.61M | 1.57% | -$8.45M |
| Savara Inc.(SVRA) | 4,000,000 | 8,157,385 | +4,157,385 | $19.92M | $32.87M | 1.54% | +$12.95M |
| ORIC Pharmaceuticals, Inc.(ORIC) | 4,142,855 | 4,142,855 | 0 | $56.96M | $29.29M | 1.37% | -$27.67M |
| CG Oncology, Inc.(CGON) | 770,000 | 770,000 | 0 | $33.80M | $24.31M | 1.14% | -$9.49M |
| PepGen Inc.(PEPG) | 1,502,788 | 1,502,788 | 0 | $22.09M | $23.98M | 1.12% | +$1.89M |
| Merus N V | 746,479 | 373,100 | -373,379 | $33.61M | $22.08M | 1.03% | -$11.54M |
| Trevi Therapeutics, Inc.(TRVI) | 7,381,090 | 7,381,090 | 0 | $25.46M | $22.00M | 1.03% | -$3.47M |
| Silence Therapeutics plcADS(SLN) | 1,148,591 | 1,148,591 | 0 | $24.81M | $21.82M | 1.02% | -$2.99M |
| Ultragenyx Pharmaceutical Inc.(RARE) | 0 | 425,000 | +425,000 | $0 | $17.47M | 0.82% | +$17.47M |
| Autolus Therapeutics plcADS(AUTL) | 4,623,324 | 4,623,324 | 0 | $29.50M | $16.09M | 0.75% | -$13.41M |
| Cerevel Therapeutics Hldng I | 393,000 | 393,000 | 0 | $16.61M | $16.07M | 0.75% | -$542.3K |
| Mereo BioPharma Group plcADS(MREO) | 0 | 4,401,371 | +4,401,371 | $0 | $15.84M | 0.74% | +$15.84M |
| Immatics N.V.SHS(IMTX) | 0 | 1,152,456 | +1,152,456 | $0 | $13.39M | 0.63% | +$13.39M |
| Tyra Biosciences, Inc.(TYRA) | 832,220 | 832,220 | 0 | $13.65M | $13.31M | 0.62% | -$341.2K |
| MacroGenics, Inc.(MGNX) | 2,471,704 | 3,010,727 | +539,023 | $36.38M | $12.80M | 0.60% | -$23.59M |
| Applied Therapeutics Inc | 1,952,857 | 2,286,135 | +333,278 | $13.28M | $10.68M | 0.50% | -$2.60M |
| Puma Biotechnology, Inc.(PBYI) | 2,816,294 | 3,062,558 | +246,264 | $14.93M | $9.98M | 0.47% | -$4.94M |
| 89bio Inc | 1,000,000 | 1,000,000 | 0 | $11.64M | $8.01M | 0.37% | -$3.63M |
| Elevation Oncology Inc | 0 | 2,958,579 | +2,958,579 | $0 | $7.99M | 0.37% | +$7.99M |
| Cogent Biosciences, Inc.(COGT) | 936,576 | 936,576 | 0 | $6.29M | $7.90M | 0.37% | +$1.60M |
| Acadia Pharmaceuticals Inc | 470,338 | 470,338 | 0 | $8.70M | $7.64M | 0.36% | -$1.05M |
| Arvinas, Inc.(ARVN) | 285,331 | 285,331 | 0 | $11.78M | $7.60M | 0.36% | -$4.18M |
| Adverum Biotechnologies Inc | 0 | 1,069,244 | +1,069,244 | $0 | $7.34M | 0.34% | +$7.34M |
| Allogene Therapeutics Inc | 2,867,750 | 2,867,750 | 0 | $12.82M | $6.68M | 0.31% | -$6.14M |
| An2 Therapeutics Inc | 1,388,889 | 2,088,889 | +700,000 | $4.51M | $4.49M | 0.21% | -$22.8K |
| Newamsterdam Pharma CompanyW EXP 11 22 202 *W EXP 99/99/999 | 500,333 | 500,333 | 0 | $5.52M | $4.36M | 0.20% | -$1.16M |
| Design Therapeutics, Inc.(DSGN) | 0 | 1,195,179 | +1,195,179 | $0 | $4.00M | 0.19% | +$4.00M |
| Immunocore Holdings plcADS(IMCR) | 0 | 108,762 | +108,762 | $0 | $3.69M | 0.17% | +$3.69M |
| Metagenomi Therapeutics, Inc.(MGX) | 279,025 | 245,692 | -33,333 | $2.94M | $1.00M | 0.05% | -$1.94M |
| Aclaris Therapeutics, Inc.(ACRS) | 264,377 | 264,377 | 0 | $327.8K | $290.8K | 0.01% | -$37.0K |
| Adverum Biotechnologies Inc | 1,069,244 | 0 | -1,069,244 | $15.12M | $0 | — | -$15.12M |
| Aerovate Therapeutics Inc | 1,204,867 | 0 | -1,204,867 | $35.63M | $0 | — | -$35.63M |
| Alpine Immune Sciences Inc | 3,131,008 | 0 | -3,131,008 | $124.11M | $0 | — | -$124.11M |
| Apellis Pharmaceuticals Inc COM | 885,165 | 0 | -885,165 | $52.03M | $0 | — | -$52.03M |
| Bluebird Bio Inc | 1,709,907 | 0 | -1,709,907 | $2.19M | $0 | — | -$2.19M |
| Deciphera Pharmaceuticals In | 1,455,837 | 0 | -1,455,837 | $22.90M | $0 | — | -$22.90M |
| Gritstone Bio Inc | 1,030,878 | 0 | -1,030,878 | $2.65M | $0 | — | -$2.65M |
| Intellia Therapeutics, Inc.(NTLA) | 203,684 | 0 | -203,684 | $5.60M | $0 | — | -$5.60M |
| Structure Therapeutics IncADS | 629,194 | 0 | -629,194 | $26.97M | $0 | — | -$26.97M |